Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-19
2011-07-19
Young, Shawquia (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S452000
Reexamination Certificate
active
07981920
ABSTRACT:
Compounds of formula (I):in-line-formulae description="In-line Formulae" end="lead"?(A)m·(B)n (I)in-line-formulae description="In-line Formulae" end="tail"?wherein A represents an angiotensin-converting enzyme inhibitor compound containing at least one salt-forming basic function, B represents a compound containing at least one salt-forming acid function and at least one NO donor group, m represents the number of acid functions of B that have been converted to a salt and n represents the number of basic functions of A that have been converted to a salt,the bond or bonds between A and B being of the ionic type.Medicinal products containing the same which are useful in treating cardiovascular pathologies.
REFERENCES:
patent: 0575754 (1993-12-01), None
patent: WO 00/12110 (2000-03-01), None
patent: WO 2004/050084 (2004-06-01), None
patent: WO 2006/078995 (2006-07-01), None
patent: WO 2006/102071 (2006-09-01), None
patent: WO 2006102071 (2006-09-01), None
patent: WO 2007/059311 (2007-05-01), None
patent: WO 2007/060112 (2007-05-01), None
Cancer and Metastasis Reviews (1998), 17(10, 91-106.
Science (1999), vol. 286, 531-537.
Cancer [online], [retrieved on Jul. 6, 2007]. Retrieved from the internet, URL http://www.nlm.nih.gov/medlineplus/cancer.html>.
Cancer [online], [retrieved on Jul. 6, 2007]. Retrieved from the internet, URL; http://en.wikipedia.org/wiki/Cancer.
Pokrovskii, M.A., et al.“Method for correcting endothelial dysfunction” Database CA, Chemical Abstract Service, Database accession No. 2006:21218242.
Persson, K., et al., “Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-converting enzymen activity and platelet aggregation in vitro” European Journal of Pharmacology vol. 406, No. 1, p. 15-23, 2000.
Wang, Peng George, et al., “Nitric oxide donors: Chemical activities and biological application” Chemical Reviews, vol. 102, No. 4, p. 1091-1134, 2002.
Stanisavljevic, Sinisa, et al., “Angiotensin I-converting enzyme inhibitors block protein kinase C.epsilon. by activating bradykinin B1 receptors in human endothelial cells” Journal of Pharmacology and Experimental Therapeutics. vol. 316, No. 3, p. 1153-1158, 2006.
Walter Haefeli, et al., “quinaprilat induces arterial vasodilation mediated by nitric oxide in humans” Database CA, Chemical Abstract Service, Database accession No. 1997:710123.
Francisco Ruiz, et al., “N-acetyl-L-cysteine protentiates depressor response to captopril and enalaprilat in SHRs”, Database CA, Chemical Abstract Service, Database accession No. 1995: 263273.
P. Massoudy, et al., “Nitric oxide accounts for postischemic cardioprotection resulting from angiotensin-converting enzymen inhibition: indirect evidence for a radical scavenger effect in isolated guinea pig heart” Database CA, Chemical Abstract Service, Database accession No. 1995:408239.
Giovanni Sorba, et al., “water soluble furoxan derivatives as NO prodrugs” Journal of Medicinal Chemistry, vol. 40, No. 4, p. 463-469, 1997.
French Preliminary Search Report for French Application No. FR 0706629, Jul. 7, 2008.
European Search Report for European Application No. EP 08290885, Nov. 7, 2008.
Benoist Alain
Courchay Christine
De Nanteuil Guillaume
Gloanec Philippe
Parmentier Jean-Gilles
Hueschen and Sage
Les Laboratoires Servier
Young Shawquia
LandOfFree
Addition salts of angiotensin-converting enzyme inhibitors... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Addition salts of angiotensin-converting enzyme inhibitors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Addition salts of angiotensin-converting enzyme inhibitors... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2740160